Innovative MedTech Inc.
IMTH · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $428 | $456 |
| % Growth | – | -100% | -6.1% | – |
| Cost of Goods Sold | $0 | $0 | $13 | $14 |
| Gross Profit | $0 | $0 | $415 | $442 |
| % Margin | – | – | 96.9% | 96.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $57 | $999 | $1,255 | $3,525 |
| SG&A Expenses | $57 | $1,074 | $1,255 | $3,525 |
| Sales & Mktg Exp. | $0 | $76 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$13 | $0 |
| Operating Expenses | $57 | $1,074 | $1,242 | $3,525 |
| Operating Income | -$57 | -$1,074 | -$827 | -$3,069 |
| % Margin | – | – | -193.1% | -672.5% |
| Other Income/Exp. Net | -$61 | -$35 | -$57 | -$3,607 |
| Pre-Tax Income | -$118 | -$1,109 | -$884 | -$6,676 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$89 | -$1,124 | -$884 | -$6,676 |
| % Margin | – | – | -206.4% | -1,462.9% |
| EPS | -0.002 | -0.036 | -0.032 | -0.28 |
| % Growth | 95.3% | -14.1% | 88.6% | – |
| EPS Diluted | -0.002 | -0.036 | -0.032 | -0.28 |
| Weighted Avg Shares Out | 52,685 | 30,893 | 27,721 | 23,882 |
| Weighted Avg Shares Out Dil | 52,685 | 30,893 | 27,721 | 23,882 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $60 | $34 | $51 | $60 |
| Depreciation & Amortization | $12 | $9 | $13 | $14 |
| EBITDA | -$46 | -$1,066 | -$819 | -$6,602 |
| % Margin | – | – | -191.2% | -1,446.7% |